Plain-English translation of NCT06324838 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a surgical technique called extended mesenteric resection—which removes more of the inflamed tissue surrounding the bowel during surgery—helps prevent Crohn's disease from returning after a portion of the intestine is removed. Half of the participants will receive this extended surgical approach, and half will receive standard surgery. Researchers will follow both groups for up to 5 years to see which approach leads to fewer cases of disease recurrence.
After surgery to remove a diseased section of bowel in Crohn's disease patients, the disease often comes back in the same area. This trial is trying to determine whether removing more of the inflamed tissue during the initial surgery can reduce that recurrence rate and improve long-term outcomes for patients.
You likely qualify if…
You likely don't qualify if…
You would undergo laparoscopic (minimally invasive) bowel surgery, randomly assigned to either standard surgical technique or the extended surgical approach being tested. After surgery, you'll have follow-up visits at 6 months and 12 months that include a scope examination of your bowel, questionnaires about your symptoms, and blood work. The study continues to monitor you through medical records for up to 5 years after surgery to track whether your disease returns and how you're doing overall.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
Denmark